Related Experiment Video

Updated: Oct 5, 2025

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus
13:00

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus

Published on: July 31, 2021

3.7K

Safety and efficiency of COVID-19 vaccination during pregnancy and breastfeeding

Ewa Blaszczyk1

  • 1Department of Pediatrics and Pediatric Endocrinology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland. ewa_p2@vp.pl.

Ginekologia Polska
|January 24, 2022
PubMed

Insights

Pregnant and breastfeeding women were excluded from vaccine trials. This review examines current data on COVID-19 vaccine safety and effectiveness in these populations to aid clinical decisions.

Area of Science:

  • Immunology
  • Vaccinology
  • Maternal Health

Background:

  • Pregnant and breastfeeding women are often excluded from clinical vaccine trials.
  • This exclusion limits data on vaccine safety and efficacy in these critical populations.
  • Evidence-based decision-making for maternal immunization requires comprehensive data.

Purpose of the Study:

  • To review existing studies on vaccine effectiveness and safety during pregnancy.
  • To consolidate current data on immunizations for breastfeeding women.
  • To provide a resource for informed medical decisions regarding maternal COVID-19 vaccination.

Main Methods:

  • Systematic literature review of published studies.
  • Analysis of data on vaccine efficacy and safety profiles.
  • Synthesis of findings related to maternal and infant outcomes.

Main Results:

  • Data on vaccine effectiveness in pregnant and breastfeeding individuals is emerging.
  • Current evidence suggests generally favorable safety profiles for approved vaccines.
  • Further research is ongoing to fully characterize long-term effects.

Conclusions:

  • Reviewing available data is crucial for guiding vaccination strategies in pregnant and breastfeeding women.
  • Continued research and data collection are necessary to ensure optimal vaccine use.
  • Informed medical decisions can improve maternal and infant health outcomes through vaccination.

More Related Videos

Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets08:12

Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets

Published on: September 6, 2019

7.3K
Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods09:04

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Published on: September 10, 2018

9.8K

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
45.6K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.0K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
21
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.1K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
485
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
534